Perceptive Advisors’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Perceptive Advisors’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,513	Closed	-$226K	–	134
2022 Q1	$226K	Sell	2,513 -1,875	-43%	-$191K	﹤0.01%	132
2021 Q4	$451K	Buy	+4,388	New	+$624K	0.01%	141

Other funds holding UTRS

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors's UTRS Position: Q2 2022 in Review

Perceptive Advisors sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q2 2022, closing a stake of 2,513 shares — an estimated $226K sold.

Perceptive Advisors first reported a position in UTRS in Q4 2021 and held it in 2 quarters. The position peaked at $451K in Q4 2021. 20 funds tracked by Wall St. Rank hold UTRS as of Q2 2022.

Perceptive Advisors reported no remaining Minerva Surgical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Perceptive Advisors sold 2,513 Minerva Surgical, Inc. Common Stock shares in Q2 2022, an estimated $226K.
Perceptive Advisors first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Perceptive Advisors's Minerva Surgical, Inc. Common Stock position peaked at $451K in Q4 2021.
20 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q2 2022.

Based on Perceptive Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.